科研之友
微信
新浪微博
Facebook
分享链接
摘要
The recent completion of the MR CLEAN trial(1) and news of early stoppage of other stroke trials demonstrates the ability for the neurointerventional community to address a crucial question that has hindered the ability of intra-arterial therapy (IAT) to be offered more widely. The focus of future studies will now shift towards improving clinical outcomes in patients undergoing IAT.
- 出版日期2015-2
